Project Grant R01AT013796
Award Date 8/7/26
Completion Date 7/31/29
Dollars Obligated $575K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke awarded the Regents of the University of Michigan a $6.827 million cooperative agreement on September 19, 2025, to conduct a Sequential Multiple Assignment Randomized Trial (SMART) evaluating personalized treatment algorithms for chronic low back pain across pharmacological, physical therapy, cognitive-behavioral, and mobile health self-management interventions. The University of Michigan's Back Pain Consortium Mechanistic Research...
- The National Institute on Drug Abuse awarded $1.403928 million to the Regents of the University of Michigan on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a remote behavioral economics-based intervention for cannabis use disorder delivered via synchronous videoconferencing. The research addresses the gap between prevalence of cannabis use disorder and treatment access: approximately 22 percent of cannabis users develop the condition, yet...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $194,298 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) for a K01 Mentored Research Scientist Development Award supporting Dr. Daniel Lee's research on cannabis use and assault injury risk in youth. The award funds a pilot study investigating near-term risk and protective factors linking cannabis use to violence among emerging adults (ages 18–25) with and without assault...
- The National Institute on Drug Abuse awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $766,538 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, to develop and test an adaptive psychological intervention for patients hospitalized after musculoskeletal injury who are receiving opioids for pain management. The intervention operates in two tiers. All eligible patients receive a low-cost,...
- The National Center for Complementary and Integrative Health awarded Vanderbilt University Medical Center $624,778 on August 31, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a multicenter feasibility clinical trial evaluating integrative health coaching for chronic low back pain in emergency department patients after discharge. The trial will test a randomized controlled design across multiple sites to assess whether remote...
- The National Center for Complementary and Integrative Health, part of the National Institutes of Health within the Department of Health and Human Services, awarded $1,671,750 to the Regents of the University of Michigan on August 11, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a pilot trial of transcutaneous electrical accustimulation (TEA) for chronic pain management in patients with cirrhosis. The recipient will conduct the...
- The National Institutes of Health National Center for Complementary and Integrative Health awarded The McLean Hospital Corporation $3.374 million on July 20, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a two-phase, milestone-driven study assessing the mechanisms and clinical impact of a high-CBD cannabinoid product on gynecologic pain. The project will evaluate a full-spectrum cannabidiol product (250 mg/ml) containing additional...
- The National Center for Complementary and Integrative Health (NCCIH) awarded the University of Massachusetts Medical School a $297,373 cooperative agreement on August 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a Data Coordinating Center (U24) to provide statistical and data management leadership for a multi-center Phase 3 randomized controlled trial (ACUITY 2) examining whether acupuncture is superior to usual care for...
- The National Institute on Drug Abuse awarded the Regents of the University of Michigan $701,995 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a National Longitudinal Study of Violence and Substance Use in the United States. The project will develop and implement a nationwide prospective digital cohort of 1,200 adults at increased risk of violence exposure. Participants will complete structured surveys every six months over a 24-month period,...
- The National Center for Complementary and Integrative Health of the Department of Health and Human Services awarded Southern California University of Health Sciences $535,524 on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to assess the quality and value of non-pharmacological therapies compared to prescription drug therapy for managing spinal pain in Medicare beneficiaries aged 65 and older. The research will use Medicare...